About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05208554

Physical Activity Intervention for Hematopoietic Cell Transplant Recipients and Caregivers

Levels of physical activity (PA) among cancer survivors are low, yet PA may ameliorate effects of treatment (Phillips et al., 2014). We focus here on PA following the most intensive form of cancer tre...

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators

Arizona State University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Scheduled to receive an autologous or allogeneic HCT.
•Being married or in a committed cohabiting relationship.
•English speaking and comprehending.
•Physician approval to participate in a walking program.
•Married to or in a cohabiting relationship with the patient.
•Able to participate in a walking program.

Exclusion Criteria

•Not scheduled to receive an HCT or already post-HCT.
•Unmarried or not in a committed cohabiting relationship.
•Non-English speaking and comprehending.
•Not medically approved to participate in walking program.
•Enrolled in competing behavioral intervention.
•Not married to or partnered/ cohabiting with the patient.
•Unable to participate in a walking program.

Related studies

RECRUITINGPhase 1

Momelotinib During and After HCT in Myelofibrosis

NCT07104799 · Myelofibrosis, Hematopoietic Cell Transplantation (HCT)

RECRUITINGPhase 3

Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation

NCT06705062 · Allogeneic Hematopoietic Cell Transplant, Graft Versus Host Disease

RECRUITINGPhase 1

CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma

NCT07257419 · Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, and more

Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation

NCT07140770 · Physical Activity, Sleep, and more

RECRUITINGPhase 3

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

NCT03394365 · Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 19, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment34

Start dateFeb 2022

Last updatedMay 19, 2025

Condition

Hematopoietic Cell Transplant

Locations shown

Mayo Clinic in Arizona

Pheonix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 19, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions